ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate has been researched along with phosphocreatine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Corr, PB; Heathers, GP; Kanter, EM; Yamada, KA | 1 |
1 other study(ies) available for ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate and phosphocreatine
Article | Year |
---|---|
Long-chain acylcarnitines mediate the hypoxia-induced increase in alpha 1-adrenergic receptors on adult canine myocytes.
Topics: Adenosine Triphosphate; Animals; Carnitine; Carnitine O-Palmitoyltransferase; Cell Survival; Creatine Kinase; Dogs; Electrophysiology; Epoxy Compounds; Hypoxia; Kinetics; L-Lactate Dehydrogenase; Myocardium; Palmitoylcarnitine; Phosphocreatine; Prazosin; Receptors, Adrenergic, alpha | 1987 |